reference/849607

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/849607

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	96
issn	0168-8278
issueIdentifier	1
pageRange	91-96
publicationName	Journal of Hepatology
startingPage	91
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_634e3b5dadc053b60b99fda0b87acb04 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_32b0a1cd7ae99f4ee32fe74686570a89
bibliographicCitation	Kagawa T, Morizane T, Saito H, Miyaguchi S, Tsunematsu S, Tada S, Guevara FM, Kumagai N, Tsuchimoto K, Watanabe T, Tsuchiya M. A randomized, controlled trial of weekly administration of lymphoblastoid interferon in patients with chronic hepatitis C. Journal of Hepatology. 1993;17(1):91–6. doi: 10.1016/s0168-8278(05)80527-6.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89278bb034b257bd3b6e83b169ab768f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eaa23ac10628a484328ccb155e241265 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d6b73ffa6f60e8c3939deb4b0c950ff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d217b9085c78fa437b499b4618a8056b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f00787c0a0603ad33744cf3bf49e1d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_258747d6a7e6c54c630c68c648601ad8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04e21bbeaa1a677a2ced3f84d5fc76aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb8063e060ad936a99b5e2d5157715a1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d68932d498441d03a8f955fd7bed9f91 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78a2591cdf5d326b129145658b0a91c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_934a8d5392fc358f9289fbd7bd92b260
date	199301
identifier	https://pubmed.ncbi.nlm.nih.gov/8445225 https://doi.org/10.1016/s0168-8278%2805%2980527-6
isPartOf	https://portal.issn.org/resource/ISSN/0168-8278 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4786
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A randomized, controlled trial of weekly administration of lymphoblastoid interferon in patients with chronic hepatitis C
discusses	http://id.nlm.nih.gov/mesh/M0000620 http://id.nlm.nih.gov/mesh/M0025711
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006526Q000628 http://id.nlm.nih.gov/mesh/D016898Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D006526Q000097 http://id.nlm.nih.gov/mesh/D000410Q000097 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D001707 http://id.nlm.nih.gov/mesh/D008111 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D002908 http://id.nlm.nih.gov/mesh/D006526Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7992 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7739 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10399

Showing number of triples: 1 to 49 of 49.